Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.28
    OpenPayerBilling CodesPre-MDCDRG 002-heart-transplant-or-implant-of-heart-assist-system-without-mcc
    Ask Trek AI about this page

    Heart Transplant or Implant of Heart Assist System without MCC: Inpatient Reimbursement Overview

    DRG 002 encompasses inpatient heart transplant or implantation of a heart assist system without Major Complication or Comorbidity, covering high-acuity cardiac surgical care and postoperative support. Accurate assignment matters for inpatient reimbursement because it determines Medicare payment classification and reflects the significant resource intensity of these procedures.

    Customize your policy alerts

    Sign up for drg 002 policy alerts

    Get alerted when payer policies referencing 002 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    DRG 002 Overview

    DRG 002 covers inpatient admissions for heart transplant or implantation of a heart assist system without Major Complication or Comorbidity. This Diagnosis-Related Group captures high-acuity cardiac surgical procedures with substantial resource use, intensive perioperative care, and specialized postoperative management. It matters for Medicare payment because it groups these complex services into a single payment classification that influences reimbursement, hospital resource allocation, and billing for transplant and mechanical circulatory support cases.

    Table of contents

    Progress1 / 3

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools

    Clinical Trials

    • Trials evaluating perioperative management strategies for heart transplant or durable mechanical circulatory support implantation: These studies test protocols for immunosuppression initiation/titration, anticoagulation, infection prophylaxis, and perioperative hemodynamic optimization in adults undergoing orthotopic heart transplantation or implantation of left ventricular assist devices (LVADs). The patient population includes critically ill candidates at high surgical risk or with end-stage heart failure requiring transplant or durable assist devices; the objective is to reduce early morbidity and mortality and shorten intensive care length of stay. Results inform clinicians about best practices to minimize complications and inform payers about resource utilization and potential cost offsets from reduced ICU days and readmissions.
    • Comparative effectiveness and device-related outcome studies for different types of mechanical circulatory support systems: These observational cohorts or randomized trials compare outcomes (survival, stroke, bleeding, device thrombosis, and quality of life) among patients receiving different generations or configurations of ventricular assist devices, or between bridge-to-transplant and destination therapy strategies. The studies focus on adult patients with advanced heart failure who are not immediate transplant candidates or who will be bridged to transplant, addressing which device or treatment pathway yields the best medium-term survival and functional status. Findings are relevant for providers deciding device selection and for payers assessing long-term care costs, complication rates, and expected post-implant resource needs.
    • Post-discharge longitudinal outcomes and readmission-reduction trials targeting transplant and LVAD recipients: These pragmatic trials and registry-based studies evaluate structured care pathways, remote monitoring, rehabilitation programs, and medication adherence interventions aimed at reducing 30- to 90-day readmissions, infectious and rejection episodes, and improving graft or device longevity. The patient population includes recent hospital discharges after heart transplantation or assist device implantation, often with complex comorbidities and high medication burden; the clinical question is which outpatient management approaches most effectively prevent costly complications. Evidence from these studies helps hospitals and payers design discharge planning, home health, and follow-up reimbursement models that improve outcomes while controlling downstream costs.

    Related Codes

    001-HEART-TRANSPLANT-OR-IMPLANT-OF-HEART-ASSIST-SYSTEM-WITH-MCC

    Heart Transplant or Implant of Heart Assist System with MCC: Inpatient Reimbursement Overview

    003-ECMO-OR-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITH-MAJOR-O-R-PROCEDURES

    ECMO or Tracheostomy with MV >96 Hours: Inpatient Reimbursement Overview

    004-TRACHEOSTOMY-WITH-MV-96-HOURS-OR-PRINCIPAL-DIAGNOSIS-EXCEPT-FACE-MOUTH-AND-NECK-WITHOUT-MAJOR-O-R-PROCEDURES

    Tracheostomy with Mechanical Ventilation >96 Hours: Inpatient Reimbursement Overview

    005-LIVER-TRANSPLANT-WITH-MCC-OR-INTESTINAL-TRANSPLANT

    Liver Transplant with MCC or Intestinal Transplant: Inpatient Reimbursement Overview

    006-LIVER-TRANSPLANT-WITHOUT-MCC

    Liver Transplant without Major Complication or Comorbidity: Inpatient Reimbursement Overview

    007-LUNG-TRANSPLANT

    Lung Transplant: Inpatient Reimbursement Overview

    008-SIMULTANEOUS-PANCREAS-AND-KIDNEY-TRANSPLANT

    Simultaneous Pancreas and Kidney Transplant: Inpatient Reimbursement Overview

    010-PANCREAS-TRANSPLANT

    Pancreas Transplant: Inpatient Reimbursement Overview

    011-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-MCC

    Tracheostomy/Laryngectomy with MCC: Inpatient Reimbursement Overview

    012-TRACHEOSTOMY-FOR-FACE-MOUTH-AND-NECK-DIAGNOSES-OR-LARYNGECTOMY-WITH-CC

    Tracheostomy and Laryngectomy with CC: Inpatient Reimbursement Overview

    Showing 1–10 of 16

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.